Pediatrix Medical Group (MD) Stock Forecast, Price & News

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Pediatrix Medical Group in the last year. There are currently 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" MD shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MD, but not buy additional shares or sell existing shares.
View MD analyst ratings or view top-rated stocks.

5 brokers have issued twelve-month price targets for Pediatrix Medical Group's shares. Their MD share price forecasts range from $14.00 to $23.00. On average, they anticipate the company's stock price to reach $17.67 in the next year. This suggests a possible upside of 32.2% from the stock's current price.
View analysts price targets for MD or view top-rated stocks among Wall Street analysts.

Pediatrix Medical Group's stock was trading at $14.86 on January 1st, 2023. Since then, MD stock has decreased by 10.1% and is now trading at $13.36.
View the best growth stocks for 2023 here.

Pediatrix Medical Group saw a decrease in short interest in the month of April. As of April 15th, there was short interest totaling 4,070,000 shares, a decrease of 5.8% from the March 31st total of 4,320,000 shares. Based on an average trading volume of 768,900 shares, the days-to-cover ratio is currently 5.3 days. Approximately 5.0% of the company's stock are sold short.
View Pediatrix Medical Group's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our MD earnings forecast.

Pediatrix Medical Group, Inc. (NYSE:MD) issued its quarterly earnings data on Thursday, October, 28th. The company reported $0.46 EPS for the quarter, topping the consensus estimate of $0.41 by $0.05. The firm earned $493 million during the quarter, compared to analyst estimates of $480.04 million. Pediatrix Medical Group had a net margin of 5.14% and a trailing twelve-month return on equity of 13.85%. The firm's revenue was up 7.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.33 EPS.

ETFs with the largest weight of Pediatrix Medical Group (NYSE:MD) stock in their portfolio include SPDR S&P Health Care Services ETF (XHS), Invesco S&P SmallCap Health Care ETF (PSCH), Roundhill Acquirers Deep Value ETF (DEEP), Pacer US Small Cap Cash Cows 100 ETF (CALF), Distillate Small/Mid Cash Flow ETF (DSMC), Syntax Stratified SmallCap ETF (SSLY), First Trust Small Cap Value AlphaDEX Fund (FYT) and iShares S&P Small-Cap 600 Value ETF (IJS).

6 employees have rated Pediatrix Medical Group Chief Executive Officer Mark S. Ordan on Glassdoor.com. Mark S. Ordan has an approval rating of 34% among the company's employees. This puts Mark S. Ordan in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Pediatrix Medical Group investors own include NVIDIA (NVDA), AbbVie (ABBV), QUALCOMM (QCOM), Gilead Sciences (GILD), Pfizer (PFE), AT&T (T), Walt Disney (DIS), Wells Fargo & Company (WFC), Exxon Mobil (XOM) and Advanced Micro Devices (AMD).

Pediatrix Medical Group trades on the New York Stock Exchange (NYSE) under the ticker symbol "MD."

Pediatrix Medical Group's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (16.10%), Dimensional Fund Advisors LP (4.61%), State Street Corp (4.08%), ArrowMark Colorado Holdings LLC (3.15%), River Road Asset Management LLC (1.91%) and Geode Capital Management LLC (1.85%). Insiders that own company stock include John C Pepia, Mark S Ordan, Nicholas J Nikolopoulos, Roger Mack Hinson, Roger Md Medel and Shirley A Weis.
View institutional ownership trends.

Shares of MD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MD stock can currently be purchased for approximately $13.36.

Pediatrix Medical Group (NYSE:MD) has a market capitalization of $1.12 billion and generates $1.97 billion in revenue each year. The company earns $66.33 million in net income (profit) each year or $1.22 on an earnings per share basis.

The company employs 5,250 workers across the globe.

Pediatrix Medical Group's mailing address is 1301 CONCORD TERRACE, SUNRISE FL, 33323. The official website for the company is www.mednax.com. The company can be reached via phone at (954) 384-0175, via email at charles_lynch@mednax.com, or via fax at 954-838-9961.